ABSTRACI'. Rates of protein turnover were measured in 20 infants receiving either Vamin Infant (group A) or Vamin 9 glucose (group B) as the amino acid source in total parenteral nutrition. A constant infusion of L-II-''~ leucine was used to measure whole body leucine flux, and leucine oxidation rates were derived from measurements of total urinary nitrogen excretion. Infants were first studied when receiving only i.v. glucose and again on each of the next 4 d as total parenteral nutrition was gradually increased to a maximum of 430 mg nitrogen/kg/d and 90 nonprotein kcal/kg/d. Net protein gain and protein synthe sis and breakdown rates increased progressively for all infants taken together over the study period as i.v. nutrition was increasing (p < 0.001). There were no differences between groups in the changes in net protein gain and rates of protein synthesis and breakdown throughout the study period. Nitrogen retention on d 5 for the two groups was similar (60 f 16% and 67 f 11% in groups A and B, respectively). In a subgroup of infants, measurements were repeated on d 8, when the intake had been constant for 3 d. Protein retention was the same as on d 5, but both synthesis and breakdown were increased. It is concluded that rates of protein turnover increase significantly in response to increasing i.v. nutrition and that this elevation was not influenced by the composition of the amino acid mixture given. (Pediatr Res 32: [447] [448] [449] [450] [451] [452] [453] [454] 1992) Abbreviations TPN, total parenteral nutrition LBWN, low birth weight neonate N, nitrogen
The controversy continues over which amino acid solution should be used for parenteral nutrition in the newborn, particularly for LBWN. There have been reports of potentially neurotoxic levels of phenylalanine ( 1-3) and high levels of other amino acids (4) in LBWN receiving Vamin 9 glucose (Kabi Pharmacia, Milton Keynes, UK), the amino acid profile of which is based on that of egg protein and was originally designed for adults. After these reports, amino acid solutions based on the profiles of breast milk protein or on the plasma profiles of postprandial breast-fed neonates have been made, resulting in lower plasma amino acid levels (5, 6) .
The majority of studies comparing different amino acid solutions have examined the effects on N balance and/or amino acid profiles (6) (7) (8) . An alternative, however, is to examine the effect on whole body protein turnover, which can be measured using stable isotopes.
[lSN]glycine has been used in LBWN receiving either a casein hydrolysate or a crystalline amino acid solution, Vamin (9) , showing that the percentage N retention was greater, and the fraction of N flux coming from endogenous protein breakdown was significantly less in LBWN who received Vamin. It was therefore inferred that Vamin was more efficacious. However, reservations regarding the use of ['SN]glycine as a tracer in neonates have been expressed (10, 1 1). The alternative procedure is the constant infusion of carbon-labeled leucine (12) . We have recently used a modification of this technique in sick, premature infants (13) and have now used this approach both to measure the progression of whole body protein turnover rates with increasing nutritional intake and to compare these rates in LBWN receiving two different amino acid solutions in TPN. The profiles of the solutions given were based on either breast milk protein (Vamin Infant, Kabi Pharmacia) or egg protein (Vamin 9 glucose), and their constituent amino acids, together with those of breast milk, are listed in Table 1 .
MATERIALS AND METHODS
Patients. Twenty LBWN were randomly allocated to receive Vamin Infant (group A, n = 11) or Vamin 9 glucose (group B, n = 9). The gestational ages (mean f SD) were 29.4 f 2.0 and 29.5 * 1.9 wk and the birth weights were 1.28 f 0.34 and 1.38 f 0.4 kg in group A and B, respectively. Infants could only be studied if there was an i.v. cannula in situ and if they were not receiving enteral feeds at the time of study. Because accurate urine collections were necessary, only male infants were included. Exclusion criteria were the presence of any metabolic disorders, renal failure, and insulin administration. Informed parental consent was obtained in all cases, and the study had the approval of Camberwell, Riverside East and West ethics committees. The clinical characteristics of all infants are listed in Table 2 . All required varying degrees of ventilatory support for respiratory distress.
Infants were first studied just before starting TPN, when they were receiving only i.v. glucose (study d 1). The d I data from eight of the infants (nos. 8-13, 17, and 18) have been reported previously (13) . The same experimental protocol was then repeated daily in each infant over the next 4 consecutive d (d [2] [3] [4] [5] and again in some infants on d 8. Thus, a total of six studies were performed on each, when this was feasible. Details of the TPN regimens used are given in Table 3 . The input of TPN was increased in an incremental fashion, to reach a maximum on study d 5, the 4th d of TPN. The decision to start TPN was made independently by the clinician concerned: this included an assessment of both the duration of time that intensive care would be needed and whether a particular neonate was likely, because Table 2 . Clinical cha of the severity of the illness, to tolerate sufficient enteral feeds to provide adequate nutrition. Infants had been maintained on i.v. glucose alone since birth, the glucose providing the amount of calories listed in the TPN regimen (Table 3) for study d I. Stable isotope administration and N balance. Each study day, infants were given a 6-h i.v. infusion of [I-"C]leucine at a dose of 6.1 ~mollkglh, preceded by a priming dose of 15.3 pmol/kg. The infusion was started at the same time each morning, which was at least 12 h after the TPN regimen had been changed. Heparinized blood samples (0.5 mL) were collected from indwelling arterial lines at 0, 2,4 and 6 h, immediately centrifuged and the plasma stored at -20°C until analysis. An accurately timed urine collection of about 12 h duration was started at the beginning of the infusion, using a closed circuit driven by a constant air pump, a modification of a method described previously (14) . With this method, air is continually blown into the urine bag, preventing development of a vacuum, while the urine is sucked into a dependent syringe outside the incubator. An additional 0.2 mL of blood were taken at 0 and 12 h for measurement of plasma urea concentration to correct N excretion values for any change in total body urea N during the urine collection ( 15) .
Laboratory analyses. The I3C enrichment of plasma leucine was measured with a VG 12-250 gas chromatograph-mass spectrometer (VG Masslab, Manchester, UK), after conversion to the tertiarybutyldimethylsilyl derivative. The ion peaks measured were m/e 302 and 303. The total N content of urine was determined by the Kjeldahl method (16) . Plasma urea measurements were made using a urease method on a Boehringer Mannheim Hitachi 7 17 (Boehringer Mannheim, Lewes, East Sussex, UK).
Calcltlation of whole body turnover rates. of measurement of whole body turnover rates with [1-'3C]leucine have been described previously (17) . Leucine enters the body free leucine pool from the diet (I) and from the degradation of whole body protein (D), whereas leucine exit is by protein synthesis (S) and leucine oxidation (0). It is assumed that the body pool of leucine remains constant in size during the infusion; this seems reasonable because TPN was infused at a constant rate and no infant was studied until at least 10 h after the last TPN infusion was changed. Hence, where Q is the total turnover rate of the free leucine pool, termed the leucine flux ( I 7). Q is calculated from the isotopic enrichment of the free leucine in plasma after a plateau value (Ep, atom % excess) has been reached, using the mean plateau I3C enrichment value. Baseline [I-13C]leucine enrichment measurements were obtained daily, before the start of each infusion, and these were subtracted from the plateau value.
where i is the L-[l-'3C]le~cine infusion rate (pmol/kg/h) and Ei is the enrichment of L-[l-13C]leucine infused (atom % excess). The rate of inflow of leucine from body protein degradation (D) is then calculated from the flux and the amount ofleucine infused per h in TPN using equation 1 and is expressed as pmol leucine/ kg/h. In the absence of direct measurements of leucine oxidation by collection of expired I3CO2, the rates of leucine oxidation (0) and incorporation of leucine by whole body protein synthesis were calculated as follows: the rate of N excretion was measured over the 12-h period and a value (N,), corrected for changes in the size of the body urea pool, calculated as described previously ( 13) . From the rate of N intake in TPN (Ni), the apparent rate of N retention (N,) was calculated.
This was not corrected for insensible losses. The rate of leucine retention in body protein (leu,) was then calculated on the assumption that leucine composes 8% of body protein [3.8 17 mmol leucine/g N (1 8)] ; thus, Leu, = N, x 3.8 17 (4) Leucine oxidation (0) was calculated as leucine intake minus leucine retention, and synthesis (in units of pmollkglh leucine) was calculated from Statistical analysis was performed by analysis of variance for repeated measures and t test for paired and grouped data with results expressed as mean * SD.
RESULTS
There was no difference between the two groups of infants in gestational age or birth weight (Table 2) Tables 4-8 , and the combined responses of all infants are illustrated in Figure 1 . As indicated in the table footnotes, where there were missing data these were calculated from the values on other days using a regression equation, before analysis of variance. These did not compose more than 10% of the total number of values so that the demonstration of significance was not distorted by the derived values. So that this limit was not exceeded, infant no. 28 was excluded from the final analysis. However, this infant was included in the analysis of those who had successful studies on d 5 and 8. Taking all the infants together, N excretion remained almost steady, but net protein gain increased significantly throughout the study (Tables 4 and 5 When the two groups were analyzed separately, there were significant increases in rates of flux and protein synthesis as the study progressed for both group A and B ( p < 0.001; tables 6 and 7). The increase in protein breakdown (Table 8) , although smaller, was significant for both groups ( p = 0.003 and p = 0.005, groups A and B, respectively). N intake was the same for the two groups throughout the study, and each group showed a significant increase in net protein gain (Table 5) as nutritional intake increased ( p < 0.001).
Comparison of the changes in rates of protein synthesis, breakdown, and net protein gain over the 5 study d showed no differences between groups A and B. The percentage of N intake that was retained (or the efficiency of N retention) was also similar (60 * 16% and 67 * 1 1%, groups A and B, respectively, on d 5). There was no correlation for rates of protein synthesis, breakdown, or N retention with gestational age, birth weight, or postnatal age.
Six infants were studied again on d 8 (infants no. 10-12, 20,
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leucinelg N, the calculated rates of protein synthesis and leucine oxidation changed, but the differences between groups A and B remained the same.
There are several possible reasons for the progressive increase in protein synthesis rates, but we think that these changes reflect the progressive increase in dietary intake. Indeed, the results showing that increases in dietary intake were accompanied by increases in synthesis and much smaller increases in protein degradation are very similar to those reported by Golden et al. (23) in children recovering from malnutrition. Moreover, in growing pigs and steers, there are similar relationships between total intake and protein synthesis and degradation (24, 25) , and in these studies increases with dietary intake could be separated from effects of increasing age by use of a randomized cross-over design. There was however, a further increase in protein synthesis in the six infants who were studied again after 3 d on maximum i.v. nutrition (study d 8, Table 9 , Fig. 2) , with a similar increase in breakdown, but there was no change in net protein gain. This increase in protein turnover may have been the result of other factors such as the improving clinical and nutritional status of the infants, which may also have contributed to the increases in protein turnover seen on d 1-5.
There was no apparent decline in the rates of increase of protein synthesis and retention at the higher intakes, suggesting that the infants were well able to tolerate the higher intakes of energy and protein on d 5. No measurements of energy expenditure were made to see whether the dietary energy intake was adequate. However, only 60% of the N given on d 5 and 8 was retained, making it unlikely that total N intake was insufficient. Indeed, greater N retention has been seen in parenterally fed LBWN receiving similar N and energy intakes (9) . However, other factors, such as the severity of illness in the present patients, would influence N retention. Moreover, it was noted that the variability in N excretion (Table 4) coincided with episodes when the infants were judged clinically to be "sicker." It is notable that in the infants studied here, positive protein retention (i.e. growth) was in some cases accompanied by a loss in body weight. This is most likely to have resulted from changes in hydration (26) .
Over the study period, there was no difference between the patterns of N retention, protein synthesis, and breakdown in the two groups, implying that there is no difference in efficacy between the two amino acid solutions. Dietary factors that might have limited protein utilization, other than the amino acid composition, were standardized for both groups so that any effect of the different constituent amino acids of the two solutions could be examined. The quantities of essential amino N in the two solutions are very similar, but the concentrations of the individual essential amino acids differed (Table 1) . Specific amino acids, such as leucine, might have the capacity to enhance protein retention (27, 28) . Moreover, the concentration of phenylalanine, lowered in Vamin Infant because of concern over
